India Cord Stem Cell Banking Market, By Source (Umbilical Cord, Placenta, Amniotic Sac, Amniotic Fluid), Utilization (Used, Unused), Application (Blood Disorders/Bone Marrow Failure, Cancers, Neurologic Disorders, Genetic Disorder, Metabolic Disorders, Immune Disorders, Others), Mode of Treatment (Autologous, Allogeneic), Service Type (Sample Preservation and Storage, Sample Processing, Sample Analysis, Sample Collection, Transportation), Cord Blood Banking (Private Cord Blood Banks, Public Cord Blood Banks), Industry Trends and Forecast to 2028.
Market Analysis and Insights of Cord Stem Cell Banking Market
Cord stem cell banking market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to grow at a CAGR of 13.1% in the above-mentioned forecast period.
Cord stem cells banking is basically storing the cord blood cell extracted from the umbilical cord and placenta of a newborn child. The umbilical cord fluid is loaded with stem cells and has more stem cells than those collected from bone marrow, which is used in medicine industry as regenerative medicine to treat disease such as leukemia, cancer, blood diseases like anemia, thalassemia, autoimmune diseases, and inherited metabolic disorders, and few others.
The increased acceptance of stem cell therapeutics, growing number of parents storing their child’s cord blood and rise in the spending on the management of chronic diseases are primary factors responsible for driving the growth of the cord stem cell banking market. Additionally, the rise in the growth in awareness about stem cell therapeutics and increase in the mergers and acquisitions by prominent players also heighten the market's overall growth. However, factors such as high operating cost of stem cell therapeutics and lack of awareness in many developing economies are estimated to obstruct the market’s growth.
The rise in the technological advancements and modernization in the healthcare devices and rising research and development activities in the healthcare sector are expected to generate profitable opportunities for the market.
This cord stem cell banking market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research cord stem cell banking market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
India Cord Stem Cell Banking Market Scope and Market Size
Cord stem cell banking market is segmented on the basis of source, utilization, application, mode of treatment system, service type and cord blood banking. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of source, the market is segmented into umbilical cord, placenta, amniotic sac and amniotic fluid.
- On the basis of utilization, the market is segmented into used and unused.
- On the basis of application, the market is segmented into blood disorders/bone marrow failure, cancers, neurologic disorders, genetic disorder, metabolic disorders, immune disorders and others.
- On the basis of mode of treatment, the market is segmented into allogeneic and autologous.
- On the basis of service type, the market is segmented into sample collection and transportation, sample processing, sample analysis and sample preservation and storage.
- On the basis of cord blood banking, the market is segmented into private cord blood banks and public cord blood banks.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Cord stem cell banking market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for cord stem cell banking market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the cord stem cell banking market. The data is available for historic period 2010 to 2019.
Competitive Landscape and India Cord Stem Cell Banking Market Share Analysis
Cord stem cell banking market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, India presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to cord stem cell banking market.
The major players covered in the cord stem cell banking market report are CBR Systems, Inc., Cordlife, Cryo-Save, LifeCell International Pvt. Ltd, StemCyte India Therapeutics Pvt. Ltd, ViaCord, SMART CELLS PLUS, Reliance Life Sciences, Cryoviva India, LifeCell, Mycord, Global Cord Blood Corporation, Cryo-Cell International, Inc., Vita 34, ReeLabs Pvt. Ltd, ACROBiosystems., Regrow Biosciences Pvt Ltd., REGROW BIOSCIENCES PVT LTD, ReeLabs Pvt. Ltd. among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF INDIA CORD STEM CELL BANKING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE INDIA CORD STEM CELL BANKING MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 INDIA CORD STEM CELL BANKING MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER’S 5 FORCES
5.3 INDIA CORD STEM CELL BANKING MARKET ANALYSIS
6 INDUSTRY INSIGHTS
6.1 DEMOGRAPHIC TRENDS
6.2 KEY PRICING STRATEGIES
6.3 KEY PATIENT ENROLLMENT STRATEGIES
6.4 INTERVIEWS WITH MANUFACTURING COMPANIES
6.5 OTHER KOL SNAPSHOTS
7 REGULATORY FRAMWORK
8 INDIA CORD STEM CELL BANKING MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
(NOTE: MARKET VALUE, MARKET VOLUME AND ASP WILL BE PROVIDED FOR ALL SEGMENTS AND SUB-SEGMENTS)
8.2 CORD BLOOD
8.2.1 RED BLOOD CELLS
8.2.2 WHITE BLOOD CELLS
8.2.3 PLATELETS
8.3 CORD CELLLS
8.3.1 HAEMATOPOIETIC STEM CELLS
8.3.2 MESENCHYMAL STEM CELLS
8.3.3 VERY SMALL EMBRYONIC-LIKE STEM CELLS
9 INDIA CORD STEM CELL BANKING MARKET, BY SOURCE
9.1 OVERVIEW
9.2 UMBILICAL CORD
9.2.1 HEMATOPOIETIC CELLS
9.2.2 MESENCHYMAL CELLS
9.3 PLACENTA
9.3.1 AMNIOTIC SAC
9.3.2 AMNIOTIC FLUID
10 INDIA CORD STEM CELL BANKING MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 BLOOD DISORDERS/BONE MARROW FAILURE
10.2.1 BY TYPE
10.2.1.1. SICKLE CELL ANEMIA
10.2.1.2. THALASSEMIA APLASTIC ANEMIA
10.2.1.3. FANCONI ANEMIA
10.2.1.4. DIAMOND-BLACKFAN ANEMIA
10.2.1.5. AMEGAKARYOCYTOSIS HISTIOCYTOSIS
10.2.1.6. OTHERS
10.2.2 BY SOURCE
10.2.2.1. UMBILICAL CORD
10.2.2.2. PLACENTA
10.2.2.3. AMNIOTIC SAC
10.2.2.4. AMNIOTIC FLUID
10.3 CANCERS
10.3.1 BY TYPE
10.3.1.1. LEUKAEMIA
10.3.1.2. LYMPHOMAS
10.3.1.3. MYELOMAS
10.3.1.4. MYELOPROLIFERATIVE NEOPLASMS
10.3.1.5. NEUROBLASTOMA
10.3.1.6. OTHER BLOOD CANCERS
10.3.2 BY SOURCE
10.3.2.1. UMBILICAL CORD
10.3.2.2. PLACENTA
10.3.2.3. AMNIOTIC SAC
10.3.2.4. AMNIOTIC FLUID
10.4 NEUROLOGIC DISORDERS
10.4.1 BY TYPE
10.4.1.1. CEREBRAL PALSY
10.4.1.2. AUTISM SPECTRUM DISORDER
10.4.1.3. TRAUMATIC BRAIN INJURY
10.4.1.4. OTHERS
10.4.2 BY SOURCE
10.4.2.1. UMBILICAL CORD
10.4.2.2. PLACENTA
10.4.2.3. AMNIOTIC SAC
10.4.2.4. AMNIOTIC FLUID
10.5 GENETIC DISORDER
10.5.1 BY TYPE
10.5.1.1. UMBILICAL CORD
10.5.1.2. PLACENTA
10.5.1.3. AMNIOTIC SAC
10.5.1.4. AMNIOTIC FLUID
10.5.2 BY SOURCE
10.5.2.1. UMBILICAL CORD
10.5.2.2. PLACENTA
10.5.2.3. AMNIOTIC SAC
10.5.2.4. AMNIOTIC FLUID
10.6 METABOLIC DISORDERS
10.6.1 BY TYPE
10.6.1.1. KRABBE DISEASE
10.6.1.2. HURLER SYNDROME
10.6.1.3. OTHERS
10.6.2 BY SOURCE
10.6.2.1. UMBILICAL CORD
10.6.2.2. PLACENTA
10.6.2.3. AMNIOTIC SAC
10.7 IMMUNE DISORDERS
10.7.1 BY TYPE
10.7.1.1. ALOPECIA AREATA
10.7.1.2. RHEUMATOID ARTHRITIS
10.7.1.3. MULTIPLE SCLEROSIS
10.7.1.4. LUPUS
10.7.1.5. DIABETES
10.7.1.6. ULCERATIVE COLITIS
10.7.1.7. OTHERS
10.7.2 BY SOURCE
10.7.2.1. UMBILICAL CORD
10.7.2.2. PLACENTA
10.7.2.3. AMNIOTIC SAC
10.7.2.4. AMNIOTIC FLUID
10.8 OTHERS
11 INDIA CORD STEM CELL BANKING MARKET, MODE OF TREATMENT
11.1 OVERVIEW
11.2 AUTOLOGOUS
11.3 ALLOGENEIC
12 INDIA CORD STEM CELL BANKING , SERVICE TYPE
12.1 OVERVIEW
12.2 SAMPLE PRESERVATION AND STORAGE
12.3 SAMPLE PROCESSING
12.4 SAMPLE ANALYSIS
12.5 SAMPLE COLLECTION AND TRANSPORTATION
12.6 OTHERS
13 INDIA CORD STEM CELL BANKING , CORD BLOOD BANKING
13.1 OVERVIEW
13.2 PRIVATE CORD BLOOD BANKS
13.2.1 BLOOD DISORDERS/BONE MARROW FAILURE
13.2.2 CANCERS
13.2.3 NEUROLOGIC DISORDERS
13.2.4 GENETIC DISORDER
13.2.5 METABOLIC DISORDERS
13.2.6 IMMUNE DISORDERS
13.2.7 OTHERS
13.3 PUBLIC CORD BLOOD BANKS
13.3.1 BLOOD DISORDERS/BONE MARROW FAILURE
13.3.2 CANCERS
13.3.3 NEUROLOGIC DISORDERS
13.3.4 GENETIC DISORDER
13.3.5 METABOLIC DISORDERS
13.3.6 IMMUNE DISORDERS
13.3.7 OTHERS
14 INDIA CORD STEM CELL BANKING MARKET, GENDER
14.1 OVERVIEW
14.2 MALE
14.3 FEMALE
15 INDIA CORD STEM CELL BANKING MARKET, BY END USER
15.1 OVERVIEW
15.2 THERAPEUTIC COMPANIES
15.3 CELL AND TISSUES BANKS
15.4 TOOLS AND REAGENT COMPANIES
15.5 SERVICE COMPANIES
15.6 RESEARCH LABORATORIES
15.7 OTHERS
16 INDIA CORD STEM CELL BANKING MARKET, BY DISTRIBUTION CHANNEL
16.1 OVERVIEW
16.2 DIRECT TENDER
16.3 RETAIL SALES
17 INDIA CORD STEM CELL BANKING MARKET, BY REGION
17.1 INDIA CORD STEM CELL BANKING MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
17.2 INDIA
18 INDIA CORD STEM CELL BANKING MARKET, COMPANY LANDSCAPE
18.1 COMPANY SHARE ANALYSIS: INDIA
18.2 MERGERS & ACQUISITIONS
18.3 NEW PRODUCT DEVELOPMENT & APPROVALS
18.4 EXPANSIONS
18.5 REGULATORY CHANGES
18.6 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
19 INDIA CORD STEM CELL BANKING MARKET, COMPANY PROFILE
19.1 LIFECELL
19.1.1 COMPANY OVERVIEW
19.1.2 REVENUE ANALYSIS
19.1.3 GEOGRAPHIC PRESENCE
19.1.4 PRODUCT PORTFOLIO
19.1.5 RECENT DEVELOPMENTS
19.2 CORD LIFE
19.2.1 COMPANY OVERVIEW
19.2.2 REVENUE ANALYSIS
19.2.3 GEOGRAPHIC PRESENCE
19.2.4 PRODUCT PORTFOLIO
19.2.5 RECENT DEVELOPMENTS
19.3 GLOBAL CORD BLOOD CORPORATION
19.3.1 COMPANY OVERVIEW
19.3.2 REVENUE ANALYSIS
19.3.3 GEOGRAPHIC PRESENCE
19.3.4 PRODUCT PORTFOLIO
19.3.5 RECENT DEVELOPMENTS
19.4 STEMCYTE INDIA THERAPEUTICS PVT. LTD (A SUBSIDIARY OF STEMCYTE)
19.4.1 COMPANY OVERVIEW
19.4.2 REVENUE ANALYSIS
19.4.3 GEOGRAPHIC PRESENCE
19.4.4 PRODUCT PORTFOLIO
19.4.5 RECENT DEVELOPMENTS
19.5 RELIANCE LIFE SCIENCES LTD
19.5.1 COMPANY OVERVIEW
19.5.2 REVENUE ANALYSIS
19.5.3 GEOGRAPHIC PRESENCE
19.5.4 PRODUCT PORTFOLIO
19.5.5 RECENT DEVELOPMENTS
19.6 CRYOVIVA INDIA
19.6.1 COMPANY OVERVIEW
19.6.2 REVENUE ANALYSIS
19.6.3 GEOGRAPHIC PRESENCE
19.6.4 PRODUCT PORTFOLIO
19.6.5 RECENT DEVELOPMENTS
19.7 INTERNATIONAL STEMCELL SERVICES LTD
19.7.1 COMPANY OVERVIEW
19.7.2 REVENUE ANALYSIS
19.7.3 GEOGRAPHIC PRESENCE
19.7.4 PRODUCT PORTFOLIO
19.7.5 RECENT DEVELOPMENTS
19.8 MYCORD (A SUBSIDIARY OF CELLUGEN BIOTECH PVT. LTD.)
19.8.1 COMPANY OVERVIEW
19.8.2 REVENUE ANALYSIS
19.8.3 GEOGRAPHIC PRESENCE
19.8.4 PRODUCT PORTFOLIO
19.8.5 RECENT DEVELOPMENTS
19.9 REELABS PVT. LTD
19.9.1 COMPANY OVERVIEW
19.9.2 REVENUE ANALYSIS
19.9.3 GEOGRAPHIC PRESENCE
19.9.4 PRODUCT PORTFOLIO
19.9.5 RECENT DEVELOPMENTS
19.1 REGROW BIOSCIENCES PVT LTD
19.10.1 COMPANY OVERVIEW
19.10.2 REVENUE ANALYSIS
19.10.3 GEOGRAPHIC PRESENCE
19.10.4 PRODUCT PORTFOLIO
19.10.5 RECENT DEVELOPMENTS
19.11 CRYO STEMCELL
19.11.1 COMPANY OVERVIEW
19.11.2 REVENUE ANALYSIS
19.11.3 GEOGRAPHIC PRESENCE
19.11.4 PRODUCT PORTFOLIO
19.11.5 RECENT DEVELOPMENTS
19.12 RENUKADIAGNOSTICS
19.12.1 COMPANY OVERVIEW
19.12.2 REVENUE ANALYSIS
19.12.3 GEOGRAPHIC PRESENCE
19.12.4 PRODUCT PORTFOLIO
19.12.5 RECENT DEVELOPMENTS
19.13 NARAYANA HRUDAYALAYA LTD
19.13.1 COMPANY OVERVIEW
19.13.2 REVENUE ANALYSIS
19.13.3 GEOGRAPHIC PRESENCE
19.13.4 PRODUCT PORTFOLIO
19.13.5 RECENT DEVELOPMENTS
19.14 PATHCARE DIAGNOSTICS
19.14.1 COMPANY OVERVIEW
19.14.2 REVENUE ANALYSIS
19.14.3 GEOGRAPHIC PRESENCE
19.14.4 PRODUCT PORTFOLIO
19.14.5 RECENT DEVELOPMENTS
19.15 CLOUDNINECARE.COM
19.15.1 COMPANY OVERVIEW
19.15.2 REVENUE ANALYSIS
19.15.3 GEOGRAPHIC PRESENCE
19.15.4 PRODUCT PORTFOLIO
19.15.5 RECENT DEVELOPMENTS
19.16 CRYOVAULT
19.16.1 COMPANY OVERVIEW
19.16.2 REVENUE ANALYSIS
19.16.3 GEOGRAPHIC PRESENCE
19.16.4 PRODUCT PORTFOLIO
19.16.5 RECENT DEVELOPMENTS
19.16.6 RECENT DEVELOPMENTS
20 CONCLUSION
21 QUESTIONNAIRE
22 ABOUT DATA BRIDGE MARKET RESEARCH
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
